Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Prediction of resistance to bevacizumab plus FOLFOX in me... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Prediction of resistance to bevacizumab plus FOLFOX in metastatic colorectal cancer—Results of the prospective multicenter PERMAD trial
0
Authors
Thomas Seufferlein
18 more
Thomas Seufferlein
•
Ludwig Lausser
16 more
•
Hans Kestler
Published
June 14, 2024
Paper
Conversation
0
Reviews
0
Bounties
0
Sign in to comment
Add a comment...
Best
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
PLoS ONE
Topics
Biology
Biochemistry
Medicine
Cancer Oncology
Immunology
Show all topics
DOI
10.1371/journal.pone.0304324
License
CC-BY
Other Formats
PDF
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
PLoS ONE
Topics
Biology
Biochemistry
Medicine
Cancer Oncology
Immunology
Show all topics
DOI
10.1371/journal.pone.0304324
License
CC-BY
Other Formats
PDF
